Gene · 5449
Papers2,504
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,504
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Temozolomide in aggressive and metastatic pituitary tumors: a Brazilian multicenter real-world cohort study. | Pituitary | 2026 | 41894067 | PubTator, text mining | PubMed |
| Targeted and Personalized Therapy for Difficult Benign Brain Tumors: A Review. | J Pers Med | 2026 | 41893038 | PubTator, text mining | PubMed |
| Calcific Aortic Valve Disease: Mechanism and Future Therapeutic Strategies. | Cells | 2026 | 41892332 | PubTator, text mining | PubMed |
| Pregnancy and delivery after surgical remission in women with prolactinomas desiring pregnancy: Refining surgical indications. | Pituitary | 2026 | 41879940 | PubTator, text mining | PubMed |
| Clinical and genetic basis of congenital gonadotropin deficiency. | Hum Reprod Open | 2026 | 41873429 | PubTator, text mining | PubMed |
| DNA methylation as a predictor of pituitary neuroendocrine tumour behaviour: A systematic review. | J Neuroendocrinol | 2026 | 41866138 | PubTator, text mining | PubMed |
| POU1F1 induces cancer stem cell-like traits in breast cancer cells by IL-6/JAK2/STAT3 activation and enrichment of ALDH. | NPJ Breast Cancer | 2026 | 41857068 | PubTator, text mining | PubMed |
| Ageing and pituitary neuroendocrine tumours (PitNETs): from bench to bedside. | Endocr Relat Cancer | 2026 | 41849686 | PubTator, text mining | PubMed |
| [Matrix metalloproteinases in pituitary adenoma invasiveness]. | Probl Endokrinol (Mosk) | 2026 | 41834597 | PubTator, text mining | PubMed |
| Transcription Factor-Based Classification of Pituitary Neuroendocrine Tumors: Practical Immunohistochemical Algorithms, Molecular Correlates, and Diagnostic Challenges in the 5th WHO Era. | Int J Mol Sci | 2026 | 41828530 | PubTator, text mining | PubMed |
| Thyrotroph Pituitary Neuroendocrine Tumors: Molecular Pathology, Diagnostic Challenges, and Receptor-Targeted Therapeutic Strategies. | Cancers (Basel) | 2026 | 41827771 | PubTator, text mining | PubMed |
| Diagnostic Utility of T-PIT, PIT-1, and SF-1 in Differentiating Pituitary Neuroendocrine Tumors From Sinonasal and Skull Base Tumors. | Appl Immunohistochem Mol Morphol | 2026 | 41808436 | PubTator, text mining | PubMed |
| Proteomic insights into the invasiveness and tumor progression of non-functioning pituitary adenomas: A scoping review. | J Neuroendocrinol | 2026 | 41795170 | PubTator, text mining | PubMed |
| Osteoarthritis: molecular pathogenesis and potential therapeutic options. | Signal Transduct Target Ther | 2026 | 41781374 | PubTator, text mining | PubMed |
| Cabergoline-Resistant Recurrent Macroprolactinoma During Pregnancy: A Case Report and Review of the Literature. | Cureus | 2026 | 41769506 | PubTator, text mining | PubMed |
| Screening of Corrosion in Storage Tank Walls and Bottoms Using an Array of Guided Wave Magnetostrictive Transducers. | Sensors (Basel) | 2026 | 41755191 | PubTator, text mining | PubMed |
| Metabolic Drivers of Valve Calcification and Atrial Remodeling in Calcific Aortic Stenosis. | Biomolecules | 2026 | 41750320 | PubTator, text mining | PubMed |
| Advances in the Understanding of Akt Signaling in Cancers and the Potential of Inhibiting Akt-Driven Tumors Using Small Molecule Inhibitors: An Overview. | Cancers (Basel) | 2026 | 41749835 | PubTator, text mining | PubMed |
| Uremic Toxin-Driven Vascular Calcification in Chronic Kidney Disease: Molecular Pathways and Integrated Phenotypes. | Toxins (Basel) | 2026 | 41745778 | PubTator, text mining | PubMed |
| Redefining Pituitary Neuroendocrine Tumors in MEN1: Prevalence, Clinical Behavior, and Implications for Long-Term Surveillance. | Curr Oncol | 2026 | 41744861 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5449/papers?page=3